Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid

Microbial Pathogenesis
N J ParsonsH Smith

Abstract

Changes in lipopolysaccharide (LPS) which occur when serum susceptible gonococci are converted to resistance by incubation with cytidine 5'-monophospho-N-acetyl neuraminic acid (CMP-NANA) have been investigated. Transfer of radioactivity to bacterial LPS from CMP-NANA labelled with 14C in the NANA moiety was detected by fluorography following lysis, proteinase K digestion and SDS-PAGE. Incorporation of radioactivity was inhibited by cytidine 5'-monophosphate (CMP). Both the radioactivity of the LPS and the resistance of gonococci to fresh human serum were largely lost after incubation with neuraminidase. No evidence was obtained to suggest that CMP-NANA is an inducer of new protein synthesis as well as a substrate for the sialylation of LPS. Little radioactivity was incorporated into components other than LPS. Sialylated, serum resistant gonococci were less able than serum susceptible gonococci to absorb the bactericidal activity of fresh human serum. Hence, we conclude that serum resistance conferred on gonococci by CMP-NANA is due to transfer of sialyl groups to surface LPS sites and this inhibits their reaction with bactericidal antibody in human serum.

Citations

Dec 1, 1990·FEMS Microbiology Immunology·A S Cross, N M Kelly
Apr 3, 2003·FEMS Microbiology Letters·Michael G Barnes, Alison A Weiss
Dec 1, 1996·FEMS Immunology and Medical Microbiology·A P MoranB J Appelmelk
May 1, 1990·The Journal of Experimental Medicine·R E MandrellM A Apicella
May 1, 1993·Molecular Microbiology·B D RobertsonJ P van Putten
Jun 1, 1995·Molecular Microbiology·J P van Putten, B D Robertson
Aug 15, 1994·Annals of the New York Academy of Sciences·S NowickiD Kumar
Feb 13, 2001·Infection and Immunity·B J WilliamsA L Smith
Feb 24, 2001·Journal of Bacteriology·D ArkingD C Stein
Oct 1, 1992·Current Opinion in Genetics & Development·J SwansonS A Hill
May 1, 1993·European Journal of Biochemistry·G O AspinallA P Moran
Jun 26, 1999·Molecular Microbiology·U Vogel, M Frosch
Nov 5, 2019·Frontiers in Immunology·Michael W RussellScott D Gray-Owen
Jan 27, 2021·Antibiotics·Katherine Y L LimCharlene M Kahler
Sep 1, 1994·Infection and Immunity·A P MoranI M Helander
Jun 1, 1994·Infection and Immunity·M LukácováH Brade
Nov 1, 1994·Infection and Immunity·R C Fernandez, A A Weiss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.